Proteases of malaria parasites: new targets for chemotherapy.
about
Chemical biology approaches for the study of apicomplexan parasitesA Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradationDiscovery of plasmepsin inhibitors by fragment-based docking and consensus scoringExpression and characterization of catalytic domain of Plasmodium falciparum subtilisin-like protease 3In silico approach to ascertain the calcium dependent role of Plasmodium falciparum SERA5.Genetic and structural characterization of PvSERA4: potential implication as therapeutic target for Plasmodium vivax malaria.Data-mining approaches reveal hidden families of proteases in the genome of malaria parasiteLabelling of four distinct trophozoite falcipains of Plasmodium falciparum by a cystatin-derived probe.New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsinsThe Plasmodium circumsporozoite protein is proteolytically processed during cell invasion.Additive in vitro antiplasmodial effect of N-alkyl and N-benzyl-1,10-phenanthroline derivatives and cysteine protease inhibitor e64.Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug developmentLooking for the exit: How do malaria parasites escape from red blood cells?Antimalarial drugs: current status and new developments.Comparative transcriptional profile of the fish parasite Cryptocaryon irritans.Potential Interaction of Plasmodium falciparum Hsp60 and CalpainProbing the structure of falcipain-3, a cysteine protease from Plasmodium falciparum: comparative protein modeling and docking studies.Functionally Expression of Metalloproteinase in Taenia solium Metacestode and Its Evaluation for Serodiagnosis of Cysticercosis.A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infectionThe marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malaria.Natural products and their biological targets: proteomic and metabolomic labeling strategies.Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.Serine protease inhibitors block invasion of host cells by Toxoplasma gondii.Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses.Determination of trace metals abnormalities in patients with vivax malaria.Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy.P. falciparum pro-histoaspartic protease (proHAP) protein peptides bind specifically to erythrocytes and inhibit the invasion process in vitro.Sequence, Structural Analysis and Metrics to Define the Unique Dynamic Features of the Flap Regions Among Aspartic Proteases.Deciphering the targets of retroviral protease inhibitors in Plasmodium bergheiAspartic protease inhibitors
P2860
Q27025364-EE27B8A9-634A-4C25-8969-8754AA048D0AQ27972584-E15ED7A6-8700-4AC8-A51B-E29E1D2052CDQ28246329-E43975E0-77A0-4EBB-9E54-02D89B2D4A3FQ30043915-49CCBFDC-EC90-448C-BB2B-11638484542DQ30383100-90095901-C169-4D31-B5FE-8E9392DD233EQ30429329-E51E8864-EC35-419B-BE62-877EBF6478D5Q30782940-7D6FDD87-20E3-4DE7-9412-FAE89686C56AQ30784188-EB0CF225-A143-4BE8-8CA1-555107CE11C2Q33982942-9261BD6C-69B0-47CD-960E-5FD3C83F60F1Q33984183-FFAC1AB4-7DEC-402F-B4B0-BC55B7F6BE93Q34158257-03B8BBD0-382B-49F6-95C3-2E78F5706A03Q34792277-CB1238A2-AEA1-4D3A-B35D-37D98ED9B85FQ35909971-3259ECC0-EB2B-4C7C-8A2A-214279F64654Q36196479-CB5EFD32-DE75-4193-9CF2-2B8E156C9D43Q36214478-0B69EE2D-3F9C-44A0-AE0E-BE2FC2A88980Q36497356-464160D5-BC8C-4E08-BC35-324A39C89570Q36559835-746F9C0D-E98B-4DE0-A6FB-DBC163078907Q36809208-5E855A2E-93D8-4B51-AC49-2BDD8250E7CCQ37335883-AD018E12-D09B-4C4E-BAB3-87B494E0F5E6Q37598633-5A03752A-BA9E-4CC5-9743-BAD4C7714AA1Q37649200-16F32A67-91E7-4A0C-BA9E-CC2DA755169DQ37718098-0411A7A4-ED85-417B-82CD-1424A0DA4756Q38066268-8974EE76-E26B-454E-ACF4-FE17E43B6D59Q39470868-13F9AF49-DD7A-492C-8109-96214E2F30ACQ40766306-094A9DB4-0147-4D6E-B708-CD6594AF391DQ41134671-E5EF328C-D423-45FE-AA02-72DF5EB64F24Q45112972-AD5207AE-52D3-4B95-914E-F4687AB5CEE0Q46495603-62079DEB-4309-4AF0-93F0-7A29B0575B51Q48001787-02481C88-2F6A-4EF1-B25B-D1BA7D8D8589Q56353634-AA122100-A66B-4B5E-BE5E-AE5C499AD8AAQ57504648-EF9A0739-8C6E-47CC-8128-C83770B3066D
P2860
Proteases of malaria parasites: new targets for chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteases of malaria parasites: new targets for chemotherapy.
@en
Proteases of malaria parasites: new targets for chemotherapy.
@nl
type
label
Proteases of malaria parasites: new targets for chemotherapy.
@en
Proteases of malaria parasites: new targets for chemotherapy.
@nl
prefLabel
Proteases of malaria parasites: new targets for chemotherapy.
@en
Proteases of malaria parasites: new targets for chemotherapy.
@nl
P2860
P921
P356
P1476
Proteases of malaria parasites: new targets for chemotherapy.
@en
P2093
Rosenthal PJ
P2860
P356
10.3201/EID0401.980107
P577
1998-01-01T00:00:00Z